DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more



Effect of GTN and Diamox Measured by BOLD-Response.

Information source: Danish Headache Center
ClinicalTrials.gov processed this data on August 23, 2015
Link to the current ClinicalTrials.gov record.

Condition(s) targeted: Healthy

Intervention: Glyceryl trinitrate, azetazolamide (Drug)

Phase: N/A

Status: Recruiting

Sponsored by: Danish Headache Center

Official(s) and/or principal investigator(s):
Messoud Ashina, MD, Phd,, Study Chair, Affiliation: Danish Headache Center

Overall contact:
Mohammad Sohail Asghar, MD, Phone: +4543232161, Email: asgsoh01@glostruphosp.kbhamt.dk

Summary

In healthy subjects different cerebral haemodynamic values wished to be determined after infusion of the NO donor Glyceryl trinitrate (GTN) and Diamox. The different values we wish to determine are:

- Blood-oxygenation-level-Dependent-signal (BOLD-signal) after visual stimulation.

- Changes in the diameter of a. cerebri media.

- Changes in the regional and global cerebral blodd flow (CBF) with the help of the

arterial Spin labeling (ASL) method.

Clinical Details

Official title: The Effect of Glyceryl Trinitrate and Diamox on Blood-Oxygenation-Level-Dependent.Signal (BOLD-Signal) and Cerebral Haemodynamics With the Use of a 3-Tesla MRI-Scan.

Study design: Allocation: Randomized, Endpoint Classification: Safety Study, Intervention Model: Crossover Assignment, Masking: Double-Blind, Primary Purpose: Educational/Counseling/Training

Primary outcome:

Changes in BOLD response

Changes in a. cerebri media diameter

Changes in CBF

Secondary outcome: headache score

Detailed description: Experimental headache models give a unike opportunity to study pathophysiological mechanisms of prim. headache types such as migraine. Previous studies have used different methods that have had limitations and none of them have had the opportunity to study neuronal activation. But that is possible with the application of functional magnetic resonance (fMRI). Before we apply fMRI to our experimental headache models it is needed to determine how the BOLD response is influenced and changed by the infusion of different drugs such as the NO donor Glyceryl Trinitrate (GTN) and Diamox (acetazolamide). It is known that GTN causes dilation of the cerebral arteries without having any effect on the regional cerebral blood flow. It is not known what effect GTN has on the BOLD response. Diamox (azetazolamide) increases the CBF but it is uncertain what effect the drug has on the BOLD response. Previous studies disagree gravely on this point. In this study we will be giving infusion of GTN and Diamox in healty subjects to determine:

- Blood-oxygenation-level-Dependent-signal (BOLD-signal) after visual stimulation.

- Changes in the diameter of a. cerebri media.

- Changes in the regional and global cerebral blodd flow (CBF) with the help of the

arterial Spin labeling (ASL) methode. For the study we will be using a 3-Tesla MRI-scan.

Eligibility

Minimum age: 18 Years. Maximum age: 55 Years. Gender(s): Both.

Criteria:

Inclusion Criteria:

- healthy subjects

- age 18-55 years

- weight 50-100 kg

Exclusion Criteria:

- Tension type headache more the once per month.

- other types of headache

- Daily use of medication other the birthcontrol pills.

- Pregnant or lactating women.

- headache on the examination date.

- contraindications to MRI-scan.

- hypotension or hypertension.

- mental illness og substance abuse.

- other significant conditions determined by the examining doctor.

Locations and Contacts

Mohammad Sohail Asghar, MD, Phone: +4543232161, Email: asgsoh01@glostruphosp.kbhamt.dk

Danish Headache Center, Glostrup 2770, Denmark; Recruiting
Mohammad Sohail Asghar, MD, Phone: +4543232161, Email: asgsoh01@glostruphosp.kbhamt.dk
Mohammad Sohail Asghar, MD, Principal Investigator
Additional Information


Last updated: August 11, 2006

Page last updated: August 23, 2015

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017